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Abstract In this prospective cohort study, we assessed
voice outcome in patients before and up to 2 years after
treatment for early glottic cancer either by radiotherapy or
by laser surgery; 106 male patients, treated for T1aN0M0
glottic cancer either by endoscopic laser surgery (n = 67)
or by radiotherapy (n = 39), participated in the study.
Patients’ voices were recorded and analysed pre-treatment
and 3, 6, 12 and 24 months post-treatment at their routine
visit at the outpatient clinic. Average fundamental fre-
quency (F0), percent jitter, percent shimmer and normal-
ized noise energy (NNE) were determined. After 2 years,
local control rate was 95% in the radiotherapy group and
97% in the laser surgery group. Larynx preservation rate
was 95% after radiotherapy and 100% after laser surgery.
Voice outcome recovers more quickly in patients treated
with laser surgery in comparison to radiotherapy: 3 months
after laser surgery there is no longer a difference with
regard to normal voices except for the fundamental
frequency, which remains higher pitched, even in the
longer term. For patients treated with radiotherapy it takes
longer for jitter, shimmer and NNE to become normal,
where jitter remains significantly different from normal
voices even after 2 years. According to these results, we
believe that laser surgery is the first treatment of choice in
the treatment of selected cases of T1a glottic carcinomas
with good functional and oncological results.
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Introduction
Until about a decade ago, radiotherapy was the first choice
of treatment for patients with early glottic cancer. Cur-
rently, it has been widely accepted that for these early
stages endoscopic laser surgery can be a safe and valid
alternative for radiotherapy. Cure rates are the major cri-
terion in determining the treatment of choice. Since both
treatment modalities provide good local control of
approximately 90%, other criteria become important in
determining the first treatment of choice [1–6].
One of these other criteria is the consideration that
radiotherapy can be delivered only once at the same target
area, while laser surgery can be performed repeatedly.
Furthermore, radiotherapy takes a much longer period of
treatment and recovery as compared to laser surgery.
Therefore, in shared decision making in clinical practice,
patients often prefer laser surgery. Another argument
against radiotherapy is that laser surgery is much more
cost-effective than radiotherapy [7–9].
Another important outcome measure is voice quality.
Several cross-sectional studies have shown that voice
outcome seems similar after both treatment modalities [10–
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17]. However, in most of these studies, information on
tumour size, time of follow-up, and type of voice analyses
is lacking. Moreover, prospective studies on voice outcome
comparing both treatment modalities for comparable T1a
lesions are scarce.
Therefore, the main purpose of this prospective cohort
study was to assess voice outcome in patients before and up
to 2 years after treatment for early glottic cancer either by
radiotherapy or laser surgery. This study was approved by
the local medical ethics committee.
Patients and methods
Patients
During a period of 9 years, 106 male patients were treated
for T1aN0M0 (T1a: tumour limited to one vocal fold with
normal mobility; N0: no regional lymph node metastasis;
M0: no distant metastasis, according to the UICC staging
system) glottic cancer. Staging was based on direct laryn-
goscopy and was proven by biopsy. Sixty-seven patients
were treated by endoscopic laser surgery (mean age
66 years; range 34–87 years) and 39 by radiotherapy
(mean age 65 years; range 44–85 years).
Twenty-one age-matched (mean age 64 years; range
50–81 years) males (spouses of patients visiting the outpa-
tient clinic) without voice problems were used as controls.
Endoscopic laser surgery
Patients treated with endoscopic laser surgery were selec-
ted by means of videolaryngostroboscopic evaluation using
the presence of mucosal undulation as an indication for
superficial tumour spread only. A Sharplan CO2-laser (with
ACU-spot micromanipulator; Sharplan Laser Industries,
Tel Aviv, Israel) in a superpulse mode was used for a
chordectomy Type II (according to the European Laryng-
ological Society (ELS) classification [18]), involving
resection of the epithelium, Reinke’s space and typically
continuing the resection just into the deeper parts of the
lamina propria. Because of this slight extension into the
deeper parts of the lamina propria, this resection does not
qualify as a type I resection, which is limited to Reinke’s
space, the superficial part of the lamina propria.
Radiotherapy
Patients not selected for laser surgery were locally irradi-
ated with the Varian CLINAC 2300, a linear 6 MV
accelerator (Varia Medical Systems Inc., Palo Alto, CA,
USA). The total radiation was 57.5–60.0 Gy (2.5 Gy per
fraction, five times a week). All patients were treated with
two opposing lateral fields, generally, with a standard field-
size of 6 9 6 cm, using 6 MV photons.
Methods
Patients’ voices were recorded and analysed pre-treatment
and 3, 6, 12 and 24 months post-treatment at their routine
visit at the outpatient clinic. Only patients were included in
the present study of whom voice assessments of at least
three of the assessment periods were completed and who
had at least one voice assessment at 12 or 24 months.
Patients who were treated for recurrence or suspicion of
recurrence of the tumour during the follow-up period were
excluded from the study.
Acoustic voice analyses
Digital recordings of a sustained vowel /a/ at comfortable
loudness and pitch were performed using Dr. Speech,
developed by Tiger Electronics (Seattle, WA). A mouth-to-
microphone distance of approximately 30 cm was held
constant throughout all samples. Acoustic signal typing
according to Behrman revealed that all recordings were
suitable for further acoustic analyses [19]. Average fun-
damental frequency (F0), percent jitter, percent shimmer
and normalized noise energy (NNE) were determined. The
percentage of jitter represents the relative period-to-period
variability. The percentage of shimmer represents the rel-
ative variability of the peak-to-peak amplitude. The nor-
malized noise energy is the degree of noise produced by
turbulent air escaping through the glottis during vocal
emission.
Statistical analyses
Independent t tests were used to compare the patient data
versus the controls for all five assessment periods. Inde-
pendent t test were also used in the comparison of voice
results between the two different therapy groups. To
investigate the longitudinal results for both treatment
groups independently, paired t tests were used between the
voice data of consecutive assessment periods.
Results
Patients
In total, 106 patients participated in the study. During the
follow-up period, 10 patients underwent a complementary
biopsy for suspicion of recurrence of the tumour and were
excluded from further voice analyses. Three of them had
been primary treated by radiotherapy, including two who
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had to be laryngectomised because of recurrence of
tumour. The other patient who had no recurrence but
merely moderate dysplasia was treated by laser surgery. Of
the other seven patients, primary treated by laser surgery,
two had tumour recurrence. One underwent radiotherapy,
and the other one, laser surgery once more. The other five
patients, primarily treated with laser surgery, suffered from
light to moderate dysplasia and were treated once more by
laser surgery (Table 1). None of the patients succumbed to
their disease during the follow-up period. Another five
patients were excluded for further analyses because they
failed to complete the required number of at least three
voice assessment moments even though they were not lost
to oncological follow-up.
Of the remaining 91 patients, 55 patients had been
treated by endoscopic laser surgery (mean age 66 years;
range 34–87 years) and 36 had been treated by radiother-
apy (mean age 66 years; range 44–85 years). Median time
of follow-up was comparable for patients treated with
radiotherapy or laser surgery (Table 2).
Voice outcome
Prospective voice outcomes are shown in Figs. 1, 2, 3, 4 of
patients treated with radiotherapy (green lines) or laser
surgery (red lines). Mean values of acoustic voice analyses
of controls were jitter 0.30 (SD = 0.18), shimmer 5.20
(SD = 1.69), NNE -9.10 (SD = 3.21), and F0 111 Hz
(SD = 24) and are represented by a blue line in Figs. 1–4.
In patients 3 months after radiotherapy, NNE was sig-
nificantly better and the fundamental frequency was sig-
nificantly lower compared to pre-treatment (t = 2.5,
p = 0.021 and t = 4.2, p = 0.000 respectively). No sig-
nificant voice changes occurred in the longer term at 6th,
12th and 24th month assessment.
In patients 3 months after laser surgery, jitter and
shimmer were significantly better compared to pre-treat-
ment (t = 3.2, p = 0.003 and t = 3.1, p = 0.004 respec-
tively). No significant voice changes occurred in the longer
term at 6th, 12th and 24th month assessment. Figures 1 to
4 represent the prospective results for jitter, shimmer, NNE
and fundamental frequency.







Recurrence 2 (5%) 2 (3%) 4 (4%)
Larynx preservation 37 (95%) 67 (100%) 104 (98%)











Median 3.3 7.1 12.4 24.7
Laser surgery
Median 3.6 6.8 12.4 24.5
Fig. 1 Prospective results of jitter for patients with T1a glottic
carcinoma treated with either laser surgery or radiotherapy, compared
with normal controls
Fig. 2 Prospective results of shimmer for patients with T1a glottic
carcinoma treated with either laser surgery or radiotherapy, compared
with normal controls
Fig. 3 Prospective results of normalized noise energy for patients
with T1a glottic carcinoma treated with either laser surgery or
radiotherapy, compared with normal controls
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Patients versus controls
Before radiotherapy, patients scored significantly worse
compared to controls regarding jitter (t = -3.1,
p = 0.001), shimmer (t = -3.1, p = 0.003), and NNE
(t = -4.3, p = 0.000) and fundamental frequency was
significantly higher (t = -6.4, p = 0.000). Three months
after radiotherapy, patients scored significantly worse
regarding jitter, shimmer, and NNE (t = -3.0, p = 0.006;
t = -2.1, p = 0.041 and t = -2.1, p = 0.042 respec-
tively). Six and 12 months after treatment, patients scored
significantly worse regarding jitter (t = -2.0, p = 0.050
and t = -2.4, p = 0.022 respectively) and fundamental
frequency (t = -2.5, p = 0.016 and t = -2.4, p = 0.022
respectively) remained significantly higher compared to
controls. Twenty-four months post treatment, jitter
remained significantly worse in patients compared to con-
trols (t = -2.8, p = 0.007).
Patients before laser surgery scored significantly worse
compared to controls regarding jitter (t = -3.1,
p = 0.003), shimmer (t = -2.5, p = 0.015), and NNE
(t = -2.4, p = 0.21) and fundamental frequency was
significantly higher (t = -6.0, p = 0.000). At 3, 6, 12 and
24 months after treatment, the fundamental frequency
remained significantly higher in comparison with controls
(t = -5.2, p = 0.000; t = -5.4, p = 0.000; t = -4.9,
p = 0.000 and t = -4.2, p = 0.000 respectively); at these
time points, all other voice outcome parameters were not
significantly different between patients and controls. See
also Table 3 and Figs. 1–4.
Radiotherapy versus laser surgery
Before treatment there was no significant difference for all
four voice outcome parameters between patients treated
with radiotherapy or laser surgery (Table 3).
Three months after treatment there was a significant
difference between the two treatment modalities with better
Fig. 4 Prospective results of fundamental frequency for patients with
T1a glottic carcinoma treated with either laser surgery or radiother-
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scores for patients treated with laser surgery regarding jitter
and shimmer (t = -2.9, p = 0.007 and t = -3.1,
p = 0.004 respectively) and higher fundamental frequency
for patients treated with laser surgery (t = 3.8, p = 0.000).
At 6, 12 and 24 months there were no significant differ-
ences any longer between the two treatment modalities
except for the fundamental frequency. Voices of patients
treated with laser surgery were significantly higher pitched
compared to patients treated by radiotherapy at 12 and
24 months after treatment (t = 2.3, p = 0.027 and t = 2.4,
p = 0.018 respectively) (Table 3).
Discussion
In this study, four out of the 106 patients developed a
recurrence, resulting in an overall local control of 96%.
Overall larynx preservation rate was 98%. When compar-
ing both treatment modalities local control rate after
2 years was 95% in the radiotherapy group and 97% in the
laser surgery group. Larynx preservation rate was 95%
after radiotherapy and 100% after laser surgery. Although
it must be kept in mind that there is some selection bias
because of the deliberate selection of tumours treatable by
laser surgery (which implies the more superficial and less
extensive tumours), it can be concluded that laser surgery
for T1a glottic carcinomas results in excellent treatment
outcome. Comparable results were found by other studies
also including only T1a glottic laryngeal carcinomas as a
homogenous study group. For example Sjo¨gren et al [2]
reported 5-year local control rates of 75% for patients after
radiotherapy respectively 89% after laser surgery of T1a
glottic carcinomas. In their study group, larynx preserva-
tion was also 100% for the laser treated patients versus
83% for the patients who received radiotherapy. Schrijvers
et al. [20] also published a better larynx preservation rate of
95% for patients treated by laser surgery versus 77% for
patients treated by radiotherapy after a follow-up of at least
41 months for T1a glottic carcinomas.
This paper describes a study investigating voice out-
come prospectively from baseline to 2 years after treatment
of patients treated with radiotherapy or laser surgery for
T1a glottic carcinoma. Earlier studies most often involved
retrospective analysis comparing measurements in a wide
range of time intervals. The present study shows that
recovery of the voice is dependent upon the time interval
since the treatment, and that both treatment modalities
result in a different recovery time regarding voice outcome.
It appears that voice outcome recovers more quickly in
patients treated with laser surgery in comparison to radio-
therapy: 3 months after laser surgery there is no longer a
difference with regard to the normal voices except for the
fundamental frequency, which remains higher pitched,
even in the longer term. For patients treated with radio-
therapy it takes longer for jitter, shimmer and NNE to
become normal, where jitter remains significantly different
from the normal voices even after 2 years.
This current study provides evidence that, except from
the fundamental frequency, in the long-term follow up
there is no lasting difference in voice outcome between
radiotherapy and laser surgery. After laser surgery the
voices remain significantly higher pitched than after
radiotherapy. This is in accordance with several other
studies where the fundamental frequency also tends to be
higher after laser surgery [11–13, 17]. This may be
explained by increased stiffness of the vocal cord due to
scar tissue after laser surgery and by a combination of scar
tissue and edema after radiotherapy. Even before treatment
the fundamental frequency is higher in both treatment
groups than in normal male controls (F0 = 111 Hz, as
found in present study) which can be attributed to a com-
bination of increased vocal fold stiffness as a result of the
tumour in combination with compensatory hyperkinetic
voicing. This finding of a higher mean fundamental fre-
quencies in patients with early glottic cancer has been
demonstrated in other studies as well with mean funda-
mental frequencies varying from 151 to 204 [21–23].
It seems logical to expect that following endoscopic
laser surgery the voice quality outcome highly depends on
the extend and depth of the resection. Roh et al [21]
divided his patients with early glottic cancer in different
groups depending on the extent of laser surgery. He found
that larger tumours and tumours involving the anterior
commissure had poor voice quality. In our study, we only
included T1a mid vocal cord tumours and pre treatment
there were no significant differences in the voices between
both treatment groups. In the light of this, it may very well
be that patients with more extensive tumours, requiring
more extended laser resections, are not better off after laser
surgery in comparison to radiotherapy from a voice out-
come point of view. Therefore, multidimensional decision
making also taking into account the experience of the
surgeon and the radiation oncologist remains an important
issue.
Based on this study and supported by others in literature
we believe that laser surgery is the first treatment of choice
in the treatment of selected cases of T1a glottic carcinomas
with good functional and oncological results.
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